Skip to the page

Data / Drug companies / Bi-Mart

Bi-Mart: 57 products in the FDA NDC directory, labeler code 37835

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Bi-Mart (labeler code 37835) lists 57 products in the FDA National Drug Code Directory, covering 35 finished drugs by generic name. By type: 57 over the counter drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on February 1, 2026.

The request: Watch Bi-Mart (FDA labeler code 37835): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
37835
Products in commercial distribution
57
Packages
83
Finished drugs by generic name
35
Prescription products
0
Over the counter products
57
Flagged as original packager
45 of 45 products that carry the flag
Started marketing in the last 12 months
2
Earliest marketing start
January 1, 2011
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs3968.4%
Generic drugs (ANDA)1831.6%

Products by type

TypeProductsShare
Over the counter drugs57100%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet2340.4%
Tablet, chewable915.8%
Capsule, liquid filled58.8%
Tablet, delayed release47%
Spray35.3%
Tablet, film coated35.3%
Liquid35.3%
Tablet, extended release23.5%
Ointment23.5%
Tablet, sugar coated11.8%
Spray, metered11.8%
Capsule11.8%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Allergy37835-633TabletOver the counter monograph drugsFebruary 1, 2026
Meclizine37835-202Tablet, chewableOver the counter monograph drugsJanuary 14, 2026
Low Dose Chewable Aspirin37835-573Tablet, chewableOver the counter monograph drugsOctober 1, 2025
Extra strength simethicone37835-233Tablet, chewableOver the counter monograph drugsSeptember 1, 2025
Oxymetazoline Hydrochloride37835-996SprayOver the counter monograph drugsAugust 1, 2025
Aspirin37835-577Tablet, film coatedOver the counter monograph drugsAugust 1, 2025
Gentle Laxative37835-244Tablet, delayed releaseOver the counter monograph drugsAugust 1, 2025
Laxative Regular Strength37835-214Tablet, sugar coatedOver the counter monograph drugsAugust 1, 2025
Natural Laxative37835-211Tablet, film coatedOver the counter monograph drugsJuly 1, 2025
Saline37835-998SprayOver the counter monograph drugsJune 1, 2025
Nighttime Sleep Aid37835-831TabletGeneric drugs (ANDA)June 1, 2025
Allergy Medicine37835-647CapsuleOver the counter monograph drugsJune 1, 2025
Mucus relief dm37835-403TabletOver the counter monograph drugsJune 1, 2025
Stomach relief37835-207TabletOver the counter monograph drugsJune 1, 2025
Famotidine37835-165TabletGeneric drugs (ANDA)June 1, 2025
Diphenhydramine HCl Maximum Strength37835-852TabletOver the counter monograph drugsMay 1, 2025
Nighttime sleep aid37835-812TabletOver the counter monograph drugsMay 1, 2025
Cetirizine hydrochloride37835-611TabletGeneric drugs (ANDA)May 1, 2025
Daytime cold and flu37835-527LiquidOver the counter monograph drugsMay 1, 2025
Nighttime cold and flu37835-525LiquidOver the counter monograph drugsMay 1, 2025
Diphenhydramine HCl37835-519LiquidOver the counter monograph drugsMay 1, 2025
Acetaminophen Extra Strength37835-507TabletOver the counter monograph drugsMay 1, 2025
Mucus Relief37835-408TabletGeneric drugs (ANDA)May 1, 2025
Mucus Relief37835-401TabletOver the counter monograph drugsMay 1, 2025
Laxative37835-241TabletOver the counter monograph drugsMay 1, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.